{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/252550162"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "Pharmaceutical formulations comprising the BPI fragments of the present invention (or physiologically-acoeptable salts thereof) as at least one of the active ingredients, would in addition comprise pharmaceutically-aoceptable carriers, diluents, fillers, salts and other materials well-known in the art depending upon the dosage form utilized." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "google.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/101497301"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/252550162" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/454175487"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/252550162"] } } }
